Le Lézard
Classified in: Health
Subjects: REL, SCZ, AVO

World Innovation Summit for Health: Symposium in Rome to Seek Ways to Enhance the Relationship Between Religion and Medical Ethics

DOHA, Qatar, Sept. 9, 2019 /PRNewswire/ -- The Pontifical Academy for Life (Vatican City) and the World Innovation Summit for Health (Qatar Foundation) have announced a joint symposium titled 'Religion and Medical Ethics: Palliative Care and the Mental Health of the Elderly', to be held in Rome on 11-12 December, 2019.

Sultana Afdhal (left), CEO of the World Innovation Summit for Health, and Archbishop Vincenzo Paglia, President of the Pontifical Academy for Life

The first day of the symposium will focus on palliative care and will provide an overview of current practices in Qatar and the Arabian Gulf region in comparison to Western practices. The sessions aim to investigate ways to tackle the ethical challenges found at the intersection of palliative care and religious bioethics.

Among the sessions will be a discussion on Muslim and Christian commonalities in approaches to palliative care that will highlight differences so as to better inform interfaith approaches to medical care. These sessions will emphasize the important role of interfaith chaplaincy in hospice palliative care. 

Discussions and presentations on the second day will focus on the mental health of the elderly. Speakers and delegates will examine the great potential benefits of religion and spirituality in improving the well-being and quality of life of elderly patients, and will explore the opportunities and challenges faced in improving quality of life through religiously informed mental health service provision from an interfaith perspective.

Additional topics being discussed across the two days include the palliative care of children and suicide among the elderly.

The academic partners for the symposium will be The BMJ, who will be represented at the event by editors of the BMJ's Journal of Medical Ethics.

Archbishop Vincenzo Paglia, President of the Pontifical Academy for Life, states: "This meeting is very important for us. Palliative care and the health of the elderly are two specific themes of great interest to our Academy; engaging in a dialogue with the Islamic world responds to the specific mandate entrusted by Pope Francis to the Pontifical Academy."

Ms. Sultana Afdhal, CEO of WISH, adds: "WISH was founded to help build a healthier world through global collaboration. We appreciate this opportunity to work closely with the Pontifical Academy for Life to help shine a spotlight on important issues at the intersection of religious and medical ethics and that deeply affect people of faith at critical times in their lives."

More detailed information on the event, plus a registration link, can be found at ethics.wish.org.qa


SOURCE World Innovation Summit for Health

These press releases may also interest you

at 04:01
For the benefit of healthcare professionals, medical researchers and the public, Elsevier, a global information analytics business specializing in science and health, has created a Novel Coronavirus Information Center with free information in English...

at 04:00
Board certified dermatologist, Dr. Jill Fichtel, director of one of the leading medical spas in Nashville, The Body Sculpting Center of Nashville in Franklin, TN, (https://www.bodysculptingcenternashville.com) is now offering free CoolSculptingtm...

at 03:43
ZTE Corporation (0763.HK/000063,SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, and Sichuan Branch of China Telecom today have realized China's first 5G remote diagnosis...

at 03:05
SpeakEasy Cannabis Club Ltd.  (the "Company" or "SpeakEasy"), a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act, is pleased to announce that it has signed a non-binding letter of intent with M&J Orchards...

at 03:00
Nourishing Biologicals, a Bio-Science company, created by North Florida surgeon, George Sadowski, M.D., to treat the cause, not the symptom, of aging skin with advanced Miracular Cellular Communicationtm announces its commitment to support women...

at 02:31
Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the patient enrollment in an investigator-initiated phase 2 study to evaluate safety, tolerability and efficacy of imlifidase in 15...

News published on 9 september 2019 at 04:01 and distributed by: